Roth Capital Downgrades Regeneron Pharma (REGN) to Neutral
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $827.72 -1.87%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Roth Capital downgraded Regeneron Pharma (NASDAQ: REGN) from Buy to Neutral, price target maintained at $78.00.
For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $78.92 yesterday.
For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $78.92 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Reiterates Sector Perform Rating on Regeneron Pharma (REGN)
- HSBC Downgrades COSCO SHIPPING Holdings Co Ltd (601919:CH) to Reduce
- Morgan Stanley Downgrades TotalEnergies SE (TTE:FP) (TTE) to Equalweight
Create E-mail Alert Related Categories
DowngradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
